Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trialFloris H.B.M. Schreuder, Catharina J.M. Klijn, Michel Remmers et al.|The Lancet Neurology|2021Cited by 101
Healthy Life-Year Costs of Treatment Speed From Arrival to Endovascular Thrombectomy in Patients With Ischemic StrokeMohammed Almekhlafi, Tobien H.C.M.L. Schreuder, Jan Albert Vos et al.|JAMA Neurology|2021Cited by 63